Skip to main content

Currently Skimming:

6 Experimentation and Innovation
Pages 95-100

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 95...
... And yet, the committee was surprised by the small number of publicly reported, evidence-based studies of the many ideas to address the issues confronting the nation's young investigators, as well as the lack of a site analogous to clinicaltrials.gov to register experiments and pilots of the type mentioned throughout this report. If the nation ­ hopes to design and sustain effective policies to support the next generation of ­ investigators, we need to hardwire into the biomedical research enterprise1 a greater ­ apacity for experimentation in policy and funding changes, followed by c assessment, publication, and adaptation or replication if successful.
From page 96...
... For example, the NIH Scientific Workforce Diversity Office has launched an anonymized review to examine biases in peer review. That office is also assessing the efficacy of implicit bias modules and investments in research on workforce diversity.
From page 97...
... The NRMN seeks to fund, implement, and evaluate innovative university approaches to research training and mentoring practices for individuals from diverse backgrounds. These programs are laudable, but integration of sustained change into the biomedical research enterprise requires a more consistent effort to support regular experimentation and innovation that consider the full range of barriers affecting the next generation of researchers.
From page 98...
... Recommendation 6.2 The National Institutes of Health should enhance the use of its Institutes and Centers as vehicles to pilot new mechanisms designed to support the independence of early-career researchers and thereby strengthen its capacity for innovation more broadly. The Biomedical Research Enterprise Council proposed in Recommendation 3.1 should monitor and evaluate those efforts.
From page 99...
... Although programs emerge from individual institutes and centers (ICs) , as well as from the NIH Office of the Director, no central and independent mechanism is charged with evaluating the performance of these experiments, and, where successful, promoting their adoption across other NIH ICs and the broader biomedical research community.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.